several formulations and methods of delivering anti - neoplastic tocopherol succinate to human subjects through transdermal and transmucosal routes to preserve its intactness are disclosed . pharmaceutically acceptable carriers such as dimethyl sulfoxide , almond oil and water are used to process tocopherol succinate at different temperatures prior to applications . by administering tocopherol succinate in this manner , the molecular form of the tocopherol succinate is preserved , resulting in enhanced efficacy of the anti - neoplastic function in human . by using the formulations and delivery methods of the invention as sole treatment , several human cancer cases had been treated successfully in a relatively short period of time .